Enhertu
Enhertu is a medicine containing Trastuzumab deruxtecan, listed in the Romanian national register of medicines for human use with 1 presentation.
General information from the official register, not medical advice. Anpheros does not diagnose and does not recommend medicines. Read the package leaflet and ask your doctor or pharmacist before taking any medicine.
At a glance
- Active substance
- TRASTUZUMABUM DERUXTECANUM
- ATC code
- L01FD04 Antineoplastic and immunomodulating agents
- Therapeutic action
- ANTICORPI MONOCLONALI SI CONJUGATI ANTICORP MEDICAMENT
- Prescription
- Prescription required (register code PRF)
- Marketing authorisation holder
- DAIICHI SANKYO EUROPE GMBH - GERMANIA
- Manufacturer
- DAIICHI SANKYO EUROPE GMBH - GERMANIA
- Pharmaceutical form
- PULB. PT. CONC. PT. SOL. PERF.
Presentations and codes
CIM is the code of each pack in the Romanian register; the Anpheros app saves it when it recognises the box.
| CIM code | Form | Strength | Pack | Prescription | Authorisation | Shelf life |
|---|---|---|---|---|---|---|
| W67658001 | PULB. PT. CONC. PT. SOL. PERF. | 100mg | Cutie cu 1 flac. din sticla bruna de 10 ml care contine 100 mg trastuzumab deruxtecan | PRF | 1508/2021/01 | 3 ani |
What it is used for
The official indications for Trastuzumab deruxtecan, quoted from the European Medicines Agency and the US FDA, are on Trastuzumab deruxtecan in Anpheros Search.
The package leaflet and the summary of product characteristics are published by ANMDMR: search for “Enhertu” in the national register.
Scan the box in Anpheros
In the Anpheros Daily app, photograph the medicine box: the app reads the name and strength, matches them against this register and adds the medicine to your list, with its code. From your list you can come back to this page.
Source: ANMDMR — National Agency for Medicines and Medical Devices of Romania, Nomenclatorul medicamentelor de uz uman (register updated 29 October 2026). Shown as published, in Romanian where the register is in Romanian.